PCK — PainChek Income Statement
0.000.00%
Last trade - 00:00- AU$61.46m
- AU$58.58m
- AU$2.67m
Annual income statement for PainChek, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.297 | 0.234 | 0.994 | 1.96 | 2.67 |
| Cost of Revenue | |||||
| Gross Profit | 0.032 | -0.405 | -0.243 | 0.719 | 0.727 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 12.7 | 6.3 | 6.71 | 9.53 | 11 |
| Operating Profit | -12.4 | -6.06 | -5.72 | -7.57 | -8.31 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.4 | -6.06 | -5.72 | -7.57 | -8.31 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.4 | -6.06 | -5.72 | -7.57 | -8.31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.4 | -6.06 | -5.72 | -7.57 | -8.31 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.4 | -6.06 | -5.72 | -7.57 | -8.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.012 | -0.005 | -0.005 | -0.006 | -0.006 |